US-Based Executive to Lead Launch of SurroSense Rx™
Calgary, AB November 17, 2014 - Orpyx Medical Technologies Inc. announced today that John Jahrstorfer has joined the team as Vice President of Sales & Marketing. In this role, Jahrstorfer will lead the company’s sales and marketing team and drive Orpyx’s launch of the SurroSense Rx system worldwide. Jahrstorfer will be based in New England.
“We couldn’t be more excited to welcome John on board as our VP Sales & Marketing,” said Orpyx Founder and CEO, Dr. Breanne Everett. “John has an exceptional track record of success in developing long-term relationships in medical device companies and growing sales. He will be instrumental to the company’s success as we introduce the SurroSense Rx system to the world.”
Jahrstorfer has spent close to 15 years leading medical sales of healthcare-related products in pharmaceutical, medical device, wound care and medical IT companies, such as Pfizer and International Computerware.
“I’m thrilled and honoured to join the team at Orpyx – a talented group of leaders with not only a passion for innovation in medical technology, but a passion for bringing true advancements to patient care and preventive medicine,” states John Jahrstorfer. “It’s no wonder why Orpyx is the leader in sensor-based wearable technology for diabetics with peripheral neuropathy”.
About Orpyx Medical Technologies:
Orpyx is a wearable pressure sensor technology company focused on medical applications. To start, Orpyx’s primary intention is to address the world’s growing epidemic of diabetes and its associated complications, most notably, lack of circulation, numbness, infection and ulcers in the feet, also known as peripheral neuropathy. This problem affects upwards of 60% of diabetics over the course of their disease and costs the health care system over $14 billion annually.
The SurroSense Rx system is a tool to help actively prevent the complications associated with peripheral neuropathy and track progress. The system is comprised of pressure-sensing inserts that wirelessly transmit feedback to the user via smartwatch or mobile application. The display alerts the user as to when pressure-induced damage is occurring so that behaviour can be proactively changed and devastating complications avoided.
In addition to the benefits of having real-time feedback, the system also tracks compliance and performance metrics over time so that the patient and primary care team and monitor progress and adjust care recommendations accordingly.
For more information, please contact:
Marketing & Inside Sales Manager, Orpyx Medical Technologies Inc.
403-460-0216 ext. 501
Download the PDF Press Release here.